Venetoclax-based combination therapy as a bridge to allogeneic hematopoietic cell transplant in children with relapsed/refractory AML

被引：0

作者：

Pfeiffer, Thomas ^{[1
]}

Li, Ying ^{[1
]}

Karol, Seth E.

Rubnitz, Jeffrey E. ^{[2
]}

Epperly, Rebecca ^{[1
]}

Madden, Renee ^{[1
]}

Mamcarz, Ewelina ^{[1
]}

Obeng, Esther A. ^{[1
]}

Qudeimat, Amr ^{[1
]}

Sharma, Akshay ^{[1
]}

Srinivasan, Ashok ^{[1
]}

Suliman, Ali ^{[1
]}

Talleur, Aimee C. ^{[1
]}

Velasquez, Mireya Paulina ^{[1
]}

Gottschalk, Stephen ^{[1
]}

Triplett, Brandon M. ^{[1
]}

Naik, Swati ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Theraphy, 332 N Lauderdale St, Memphis, TN 38105 USA

[2] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA

来源：

PEDIATRIC BLOOD & CANCER | 2022年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1

共 50 条

[1] Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
Thomas Pfeiffer
Ying Li
Emily Ashcraft
Seth E. Karol
Jeffrey E. Rubnitz
Rebecca Epperly
Renee Madden
Ewelina Mamcarz
Esther Obeng
Amr Qudeimat
Akshay Sharma
Ashok Srinivasan
Ali Suliman
Aimee C. Talleur
M. Paulina Velasquez
Stephen Gottschalk
Brandon M. Triplett
Swati Naik
Bone Marrow Transplantation, 2023, 58 : 328 - 331
[2] Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
Pfeiffer, Thomas
Li, Ying
Ashcraft, Emily
Karol, Seth E.
Rubnitz, Jeffrey E.
Epperly, Rebecca
Madden, Renee
Mamcarz, Ewelina
Obeng, Esther
Qudeimat, Amr
Sharma, Akshay
Srinivasan, Ashok
Suliman, Ali
Talleur, Aimee C.
Velasquez, M. Paulina
Gottschalk, Stephen
Triplett, Brandon M.
Naik, Swati
BONE MARROW TRANSPLANTATION, 2023, 58 (03) : 328 - 331
[3] Salvage use of venetoclax-based Therapy for Relapsed AML Post Allogeneic Hematopoietic Stem Cell Transplant
Cook, Joselle
Joshi, Maansi
Gangat, Naseema
Pardanani, Animesh
Tefferi, Ayalew
Begna, Kebede
Elliot, Michelle
Al-Kali, Aref
Patnaik, Mrinal
Shah, Mithun V.
Hogan, William J.
Litzow, Mark
Alkhateeb, Hassan B.
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 191 - 191
[4] Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
Unglaub, Julia M.
Schlenk, Richard F.
Middeke, Jan Moritz
Krause, Stefan W.
Kraus, Sabrina
Einsele, Hermann
Kramer, Michael
Zukunft, Sven
Kauer, Joseph
Renders, Simon
Katelari, Elena
Schliemann, Christoph
Pabst, Caroline
Luft, Thomas
Dreger, Peter
Roellig, Christoph
Bornhaeuser, Martin
Mueller-Tidow, Carsten
Sauer, Tim
Study Alliance Leukemia
BLOOD ADVANCES, 2025, 9 (02) : 375 - 385
[5] Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
Joshi, Maansi
Cook, Joselle
McCullough, Kristen
Nanaa, Ahmad
Gangat, Naseema
Foran, James M.
Murthy, Hemant S.
Kharfan-Dabaja, Mohamed A.
Sproat, Lisa
Palmer, Jeanne
Pardanani, Animesh
Tefferi, Ayalew
Begna, Kebede
Elliot, Michelle
Al-Kali, Aref
Patnaik, Mrinal
Shah, Mithun V.
Hogan, William J.
Litzow, Mark R.
Alkhateeb, Hassan B.
BLOOD CANCER JOURNAL, 2021, 11 (03)
[6] Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
Maansi Joshi
Joselle Cook
Kristen McCullough
Ahmad Nanaa
Naseema Gangat
James M. Foran
Hemant S. Murthy
Mohamed A. Kharfan-Dabaja
Lisa Sproat
Jeanne Palmer
Animesh Pardanani
Ayalew Tefferi
Kebede Begna
Michelle Elliot
Aref Al-Kali
Mrinal Patnaik
Mithun V. Shah
William J. Hogan
Mark R. Litzow
Hassan B. Alkhateeb
Blood Cancer Journal, 11
[7] Efficacy of Venetoclax-Based Therapy Followed By Allogeneic Transplantation in Newly Diagnosed and Relapsed/Refractory AML Patients
Fanin, Matteo
Lazzarotto, Davide
Sperotto, Alessandra
Tanasi, Ilaria
Leoncin, Matteo
Gurrieri, Carmela
Fili, Carla
Callegari, Chiara
Battaglia, Giulia
Simeone, Erica
Zannier, Maria Elena
Tosoni, Luca
Morelli, Gian Luca
Bergnach, Melissa
Gottardi, Michele
Tamellini, Edoardo
Consolo, Sara
Skert, Cristina
Angotzi, Francesco
Lessi, Federica
Krampera, Mauro
Patriarca, Francesca
Damiani, Daniela
Fanin, Renato
Tiribelli, Mario
BLOOD, 2024, 144 : 6038 - 6039
[8] Optimal therapeutic strategies in relapsed/refractory AML with prior exposure to venetoclax-based therapy
Bawek, Sawyer
Burwinkel, Matthew
Patel, Prutha
Wang, Katy
Attwood, Kristopher
Cronin, Tara
Fos, Melissa
Green, Steven
Sung, Pamela J.
Thompson, James E.
Griffiths, Elizabeth A.
Wang, Eunice S.
Przespolewski, Amanda C.
LEUKEMIA RESEARCH, 2025, 150
[9] Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Bewersdorf, Jan Philipp
Derkach, Andriy
Gowda, Lohith
Menghrajani, Kamal
DeWolf, Susan
Ruiz, Josel D.
Ponce, Doris M.
Shaffer, Brian C.
Tamari, Roni
Young, James W.
Jakubowski, Ann A.
Gyurkocza, Boglarka
Chan, Alexander
Xiao, Wenbin
Glass, Jacob
King, Amber C.
Cai, Sheng F.
Daniyan, Anthony
Famulare, Christopher
Cuello, Bernadette M.
Podoltsev, Nikolai A.
Roshal, Mikhail
Giralt, Sergio
Perales, Miguel-Angel
Seropian, Stuart
Cho, Christina
Zeidan, Amer M.
Prebet, Thomas
Stein, Eytan M.
Tallman, Martin S.
Goldberg, Aaron D.
Stahl, Maximilian
LEUKEMIA & LYMPHOMA, 2021, 62 (14) : 3394 - 3401
[10] Monocentric experience of venetoclax-based regimen in paediatric refractory and relapsed AML/MDS
Cousson, Sophie
Calvo, Charlotte
Goldwirt, Lauriane
Simonin, Mathieu
Roupret-Serzec, Julie
Dourthe, Marie Emilie
Strullu, Marion
Baruchel, Andre
Dalle, Jean-Hugues
Brethon, Benoit
BRITISH JOURNAL OF HAEMATOLOGY, 2024,

← 1 2 3 4 5 →